D-1520-2020 Class II Terminated

Recalled by Calvin Scott & Company, Inc. — Albuquerque, NM

FDA drug recall D-1520-2020 was initiated by Calvin Scott & Company, Inc. on Jul 27, 2020 and is designated Class II. Reason for recall: CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches. The recall status is terminated (terminated Apr 11, 2024).

Recall Details

Product Type
Drugs
Report Date
Aug 26, 2020
Initiation Date
Jul 27, 2020
Termination Date
Apr 11, 2024
Voluntary/Mandated
Voluntary: Firm initiated

Product Description

Topiramate 25mg Tabs White/round tablets, 10-count bags, Distributed by: Calvin Scott & Co., Inc. Alb., MN 87123, Mfg: Sun Pharm., Inc. Cranbury, NJ 08512, NDC 47335-0707-13

Reason for Recall

CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.

Distribution Pattern

Nationwide within the United States

Code Information

Lot #: 19234; Exp. Date: 9/20

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1520-2020
openFDA file date
Nov 3, 2026
Loaded by RegDataLab
Nov 4, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1520-2020. Report a data issue: hello@regdatalab.com.